The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Epidemiology of DSM-5 bipolar I disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions – III
Open accessAbstract
Background The objective of this study was to present 12-month and lifetime prevalence, correlates, comorbidity, treatment and disability of DSM-5 bipolar I disorder. Methods Nationally representative U.S. adult sample (N = 36,309), the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions - III. Results Prevalences of 12-month and lifetime DSM-5 bipolar I disorder were 1.5% and 2.1% and did not differ between men (1.6% and 2.2%) and women (1.5% and 2.0%). Prevalences of bipolar I disorder were greater among Native Americans, and lower among Blacks, Hispanics and Asians/Pacific Islanders than whites. Rates were also lower among younger than older individuals, those previously married than currently married and with lower education and income relative to higher education and income. Bipolar I disorder was more strongly related to borderline and schizotypal personality disorders (adjusted odds ratios (AORS) = 2.2-4.7)), than to anxiety disorders (AORs = 1.3-2.9), and substance use disorders (AORs = 1.3-2.1) overall and among men and women. Quality of life was lower among individuals with bipolar I disorder relative to those without the disorder. Treatment rates among individuals with bipolar I disorder were low in the total sample (46%, SE = 2.63), among men (36.7%, SE = 3.82) and among women (55.8%, SE = 3.32). Conclusions Bipolar I disorder continues to be common disabling and highly comorbid disorder among men and women, contributing substantially to low quality of life and burden of disease in our society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders
(2012) · Springer eBooks · doi:10.1007/springerreference_121117 · Cited by 20,772
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,603
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Self-citationMerikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., Smith, S. M., Dawson, D. S., Pulay, A. J., Pickering, R. P., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0404 · Cited by 1,618
Self-citationDiagnostic and Statistical Manual of Mental Disorders
Preedy, V., & Watson, R. (2010) · Springer eBooks · doi:10.1007/978-0-387-78665-0_5485 · Cited by 1,146
McGuire, S. (2014) · Advances in Nutrition · doi:10.3945/an.114.007211 · Cited by 1,107
Cited by
Sorted by citations
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737
Self-citationVieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Epidemiology and risk factors for bipolar disorder
Rowland, T., & Marwaha, S. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318769235 · Cited by 540
Bipolar depression: the clinical characteristics and unmet needs of a complex disorder
McIntyre, R. S., & Calabrese, J. R. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1636017 · Cited by 211
Earley, W. R., Burgess, M. V., Rekeda, L., Dickinson, R., Szatmári, B., Németh, G., McIntyre, R. S., Sachs, G. S., & Yatham, L. N. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18070824 · Cited by 180
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s259338 · Cited by 147
Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges
Kim, Y., Santos, R., Gage, F. H., & Marchetto, M. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00030 · Cited by 127
Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction
Reginsson, G. W., Ingason, A., Euesden, J., Bjornsdottir, G., Olafsson, S., Sigurdsson, E., Oskarsson, H., Tyrfingsson, T., Runarsdottir, V., Hansdottir, I., et al. (2018) · Addiction Biology · doi:10.1111/adb.12496 · Cited by 112
Chen, M.-H., Hsu, J.-W., Huang, K.-L., Su, T.-P., Li, C.-T., Lin, W.-C., Tsai, S.-J., Cheng, C.-M., Chang, W.-H., Pan, T.-L., et al. (2019) · Psychological Medicine · doi:10.1017/s003329171800332x · Cited by 106
McGirr, A., Vila-Rodriguez, F., Cole, J., Torres, I. J., Arumugham, S. S., Keramatian, K., Saraf, G., Lam, R. W., Chakrabarty, T., & Yatham, L. N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.0963 · Cited by 76
Where Sex Meets Gender: How Sex and Gender Come Together to Cause Sex Differences in Mental Illness
Christiansen, D. M., McCarthy, M. M., & Seeman, M. V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.856436 · Cited by 65
The importance and implications of comparator selection in pharmacoepidemiologic research
D’Arcy, M. E., Stürmer, T., & Lund, J. L. (2018) · Current Epidemiology Reports · doi:10.1007/s40471-018-0155-y · Cited by 62
Gates, M., Turney, A., Ferguson, E., Walker, V., & Staples-Horne, M. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14030317 · Cited by 58
Suicidal behavior across a broad range of psychiatric disorders
Xu, Y. E., Barron, D. A., Sudol, K., Zisook, S., & Oquendo, M. A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01935-7 · Cited by 62
Zhang, S., Lin, X., Yang, T., Zhang, S., Pan, Y., Lu, J., & Liu, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.001 · Cited by 49
Godman, B., Grobler, C., Van-De-Lisle, M., Wale, J., Barbosa, W. B., Massele, A. Y., Opondo, P. R., Petrova, G. I., Tachkov, K., Sefah, I. A., et al. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1684473 · Cited by 48
Stokes, P. R. A., Jokinen, T., Amawi, S. O., Qureshi, M. M., Husain, M. I., Yatham, L. N., Strang, J., & Young, A. H. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720915420 · Cited by 48
Metabolic Syndrome Impairs Executive Function in Bipolar Disorder
Dalkner, N., Bengesser, S., Birner, A., Fellendorf, F. T., Fleischmann, E., Großschädl, K., Lenger, M., Maget, A., Platzer, M., Queissner, R., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.717824 · Cited by 46
Chen, M., Hsu, J.-W., Huang, K., Tsai, S., Su, T., Li, C., Lin, W.-C., Tu, P., & Bai, Y. (2020) · CNS Spectrums · doi:10.1017/s1092852920001534 · Cited by 44
Greene, M., Paladini, L. M., Lemmer, T., Piedade, A., Touya, M., & Clark, O. A. C. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s166730 · Cited by 44
Johnson, J. C. S., Byrne, G. J., & Pelecanos, A. M. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03834-1 · Cited by 36
Chen, M., Tsai, S., Su, T., Li, C., Lin, W., Cheng, C., Chen, T., & Bai, Y. (2021) · International Journal of Cancer · doi:10.1002/ijc.33914 · Cited by 31
Chakrabarti, S. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i12.1335 · Cited by 30
Earley, W. R., Burgess, M. V., Rekeda, L., Hankinson, A. L., McIntyre, R. S., Suppes, T. M., Calabrese, J. R., & Yatham, L. N. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.098 · Cited by 27
Gordon‐Smith, K., Lewis, K. S., Auñón, F. M. V., Florio, A. D., Perry, A., Craddock, N. J., Jones, I. R., & Jones, L. A. (2020) · Bipolar Disorders · doi:10.1111/bdi.12905 · Cited by 29
COVID-19: Implications for bipolar disorder clinical care and research
Xue, S., Husain, M. I., Ortiz, A., Husain, M. O., Daskalakis, Z. J., & Mulsant, B. H. (2020) · SAGE Open Medicine · doi:10.1177/2050312120981178 · Cited by 27
Revisiting the wandering womb: Oxytocin in endometriosis and bipolar disorder
Dinsdale, N. L., & Crespi, B. J. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.09.005 · Cited by 27
Wai, J. M., Shulman, M., & Nunes, E. V. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb44 · Cited by 23
Loebel, A. D., Koblan, K. S., Tsai, J., Deng, L., D, M. F. M., KENT, J. M., & Hopkins, S. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.109 · Cited by 22
Regulation of Inositol Biosynthesis: Balancing Health and Pathophysiology
Case, K. C., Salsaa, M., Yu, W., & Greenberg, M. L. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_181 · Cited by 22
Chen, M., Hsu, J.-W., Huang, K., Tsai, S., Su, T., Li, C., Lin, W.-C., Tu, P., & Bai, Y. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1819566 · Cited by 20
Dalkner, N., Ratzenhofer, M., Fleischmann, E., Fellendorf, F. T., Bengesser, S., Birner, A., Maget, A., Großschädl, K., Lenger, M., Platzer, M., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114451 · Cited by 18
Patel, M., Jain, R., Tohen, M. F., Maletic, V., Earley, W. R., & Yatham, L. N. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000344 · Cited by 19
Bastos, J. D. R., Perico, K. M., Vieira, É. L. M., Teixeira, A. L., Machado, F. S., de Miranda, A. S., & Moreira, F. A. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.004 · Cited by 17
Datta, S., Suryadevara, U., & Cheong, J. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001051 · Cited by 21
Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder
Naglich, A. C., Adinoff, B. H., & Brown, E. S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0449-5 · Cited by 23
Fink, D. S., Shmulewitz, D., Mannes, Z. L., Stohl, M., Livne, O., Wall, M. M., & Hasin, D. S. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.09.016 · Cited by 16
Franklin, C., & Dwyer, D. S. (2020) · Bipolar Disorders · doi:10.1111/bdi.12996 · Cited by 15
Acetylsalicylic Acid and Mood Disorders: A Systematic Review
Dominiak, M., Gędek, A., Sikorska, M., Mierzejewski, P., Wojnar, M., & Antosik-Wójcińska, A. Z. (2022) · Pharmaceuticals · doi:10.3390/ph16010067 · Cited by 16
Fico, G., Oliva, V., Prisco, M. D., Giménez‐Palomo, A., Sagué‐Vilavella, M., Gomes‐da‐Costa, S., Garriga, M., Solé, E., Valentí, M., Fanelli, G., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.05.004 · Cited by 17
Ghazi-Noori, A.-R., Woodham, R. D., Rezaei, H., Sharif, M. S., Bramon, E., Ritter, P. S., Bauer, M., Young, A. H., & Fu, C. H. Y. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00352-9 · Cited by 14
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425787.x03_bipolar_and_related_disorders · Cited by 17
Predictors of quality of life in bipolar disorder: A path analytical study
Cotrena, C., Branco, L. D., Shansis, F., & Fonseca, R. P. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112846 · Cited by 14
Alhelali, A., Almheiri, E., Abdelnaim, M. A., Weber, F. C., Langguth, B., Schecklmann, M., & Hebel, T. (2022) · Brain Sciences · doi:10.3390/brainsci12030298 · Cited by 13
Haitana, T., Pitama, S. G., Cormack, D. M., Clark, M. T. R., & Lacey, C. J. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211031490 · Cited by 14
Forma, F. M., Chiu, K., Shafrin, J. T., Boskovic, D. H., & Veeranki, S. P. (2022) · Digital Health · doi:10.1177/20552076221084472 · Cited by 12
Haitana, T., Pitama, S. G., Cormack, D. M., Clark, M. T. R., & Lacey, C. J. (2022) · Ethnicity and Health · doi:10.1080/13557858.2022.2027884 · Cited by 12
Fire and Darkness: On the Assessment and Management of Bipolar Disorder
Nikolitch, K., Saraf, G., Solmi, M., Kroenke, K., & Fiedorowicz, J. G. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.04.002 · Cited by 12
Racial differences in the major clinical symptom domains of bipolar disorder
Li, K. D., Richards, E. M., & Goes, F. S. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00299-3 · Cited by 11
Bertocci, M. A., Bergman, J., Santos, J. P. L., Iyengar, S., Bonar, L. K., Gill, M. K., Abdul‐waalee, H., Bebko, G. M., Stiffler, R. S., Lockovich, J., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01048-1 · Cited by 11
Tohen, M. F. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s240860 · Cited by 11
Co-occurring Mood and Substance Use Disorders
Wai, J. M., Shulman, M., Nunes, E. V., Hasin, D. S., & Weiss, R. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_91 · Cited by 11
Icick, R., Gard, S., M’Baïlara, K., Biseul, I., Samalin, L., Brousse, G., Flaudias, V., Llorca, P., Loftus, J., Cussac, I., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.03.041 · Cited by 11
Doane, M. J., Ogden, K., Bessonova, L., O’Sullivan, A. K., & Tohen, M. F. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s280051 · Cited by 12
Percutaneous transport of psychotropic agents
Ita, K. B. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.04.009 · Cited by 10
Bipolar disorder and addictions: The elephant in the room
Stokes, P. R. A., Kalk, N. J., & Young, A. H. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.193912 · Cited by 10
Teipel, S. J., Akmatov, M. K., Michalowsky, B., Riedel-Heller, S. G., Bohlken, J., & Holstiege, J. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01662-x · Cited by 10
Schlüter, P. J., Lacey, C. J., Porter, R., & Jamieson, H. A. (2017) · Bipolar Disorders · doi:10.1111/bdi.12511 · Cited by 8
Ikawa, H., Osawa, R., Takeda, Y., Sato, A., Mizuno, H., & Noda, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27288 · Cited by 7
Yang, X., & Zou, D. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001104 · Cited by 8
Tietz, S., Wagner‐Skacel, J., Angel, H., Ratzenhofer, M., Fellendorf, F. T., Fleischmann, E., Körner, C., Reininghaus, E. Z., Seitz, R. J., & Dalkner, N. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i7.929 · Cited by 9
Augusto, M., Greene, M., Touya, M., Sweeney, S. M., & Waters, H. C. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0010 · Cited by 8
Ventura, F., Frias, P., da Silva, D. R., McGirr, A., Cotovio, G., & Oliveira-Maia, A. J. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100618 · Cited by 8
Why religion and spirituality are important in human biological research
Lynn, C. D., & Schell, L. M. (2024) · American Journal of Human Biology · doi:10.1002/ajhb.24106 · Cited by 8
Single, A. N., Alcolado, G. M., Keough, M. T., & Mota, N. P. (2023) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2023.102808 · Cited by 11
Physical and mental health status of former smokers and non‐smokers patients with bipolar disorder
Nobile, B., Godin, O., Gard, S., Samalin, L., Brousse, G., Loftus, J., Aubin, V., Belzeaux-R, R., Dubertret, C., Strat, Y. L., et al. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13535 · Cited by 7
Genetics of Bipolar Spectrum Disorders: Focus on Family Studies Using Whole Exome Sequencing
Kasyanov, E. D., Merkulova, T. V., Kibitov, A. O., & Mazo, G. E. (2020) · Russian Journal of Genetics · doi:10.1134/s1022795420070054 · Cited by 6
Leung, N., Bernacki, S. E., Kalia, N., Bernacki, E. J., & Almeida, J. R. C. (2021) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002465 · Cited by 7
Gao, K., Ayati, M., Kaye, N. M., Koyutürk, M., Calabrese, J. R., Ganocy, S. J., Lazarus, H. M., Christian, E., & Kaplan, D. R. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.058 · Cited by 6
Clinical characteristics and impacts of HIV infection in people with bipolar disorders
Yalın, N., Conti, I., Bagchi, S., Essig, A., Bird, C., Adlington, K., Everall, I., & Stokes, P. R. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.077 · Cited by 6
Place of care and costs associated with acute episodes and remission in bipolar I disorder
McIntyre, R. S., Higa, S., Doan, Q. V., Amari, D. T., Oliveri, D., Gillard, P. J., & Harrington, A. (2022) · Journal of Medical Economics · doi:10.1080/13696998.2022.2120264 · Cited by 6
Editorial: Comorbidity in bipolar disorder and schizophrenia, volume III
Martinotti, G., Fornaro, M., & Berardis, D. D. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1356817 · Cited by 6
Augusto, M., Greene, M., Touya, M., Sweeney, S. M., & Waters, H. C. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0009 · Cited by 5
Arrieta, M., & Santos, P. M. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.09.013 · Cited by 10
The role of oxytocin in the pathogenesis of endometriosis: various aspects of the problem
Yarmolinskaya, M. I., & Khobets, V. V. (2019) · Journal of obstetrics and women s diseases · doi:10.17816/jowd68389-98 · Cited by 5
Psychopharmacology and Experimental Therapeutics for Bipolar Depression
Jha, M. K., & Murrough, J. W. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20190009 · Cited by 5
Physical fitness in patients with bipolar disorder compared with a population‐based sample
Kheradmand, A., AbediYekta, A. H., Safarzadeh, H., & Ganjalikhani, M. (2022) · Health Science Reports · doi:10.1002/hsr2.507 · Cited by 4
Glastad, S. H., Aminoff, S. R., Hagen, R., Høegh, M. C., Büchmann, C. B., Barrett, E. A., Melle, I. S., Étain, B., & Lagerberg, T. V. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.003 · Cited by 4
Öksüz, E., Mersin, S., Uçgun, T., & SARIKOÇ, G. (2024) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2024.03.005 · Cited by 4
Salem, A., Shah, N. K., Geraldi-Samara, D., Elangovan, N., & Krzyzak, M. (2018) · Cureus · doi:10.7759/cureus.3242 · Cited by 4
Editorial: Comorbidity in bipolar disorder, volume II
Berardis, D. D., Fornaro, M., & Carmassi, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1115357 · Cited by 4
A Retrospective Cross-Sectional Analysis of the Humanistic and Economic Burden of Bipolar I Disorder
Culpepper, L., Martin, A., Harrington, A., Wade, S. W., & Parikh, M. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.08.003 · Cited by 6
Bonner-Reid, F. T., Dar, A., Zerin, A., Mishra, A. P., Lollobattista, C., Narasimhan, N., Desai, S., & Singh, S. (2025) · Cureus · doi:10.7759/cureus.86363 · Cited by 3
Emotional wellbeing in neurodivergent populations
Pincus, J. D., & Beller, K. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1606232 · Cited by 4
Tohen, M. F., Durgam, S., Kozauer, S. G., Chen, C., Davis, R. E., & Mates, S. L. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000596 · Cited by 3
Sexual Dysfunctions and Mood and Anxiety Disorders
Niolu, C., Lisi, G., & Siracusano, A. (2018) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-68306-5_9 · Cited by 3
Cetkovich, M., Abadi, A. F., Camino, S., Bonetto, G. G., Herbst, L., Marengo, E., Torrente, F. M., Maresca, T., Bustin, J., Morra, C. A., et al. (2022) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v33i158.319 · Cited by 5
Lynum, K. S. B., Castro, C. F., Zhang, Z., Patel, M., & Tohen, M. F. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00358-3 · Cited by 3
Schönthaler, E. M. D., Dalkner, N., Stross, T. M., Bengesser, S., Ilic, J., Fellendorf, F. T., Finner, A., Fleischmann, E., Häussl, A., Georgi, J., et al. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1479648 · Cited by 3
Glastad, S. H., Klungsøyr, O., Aminoff, S. R., Hagen, R., Bjella, T. D., Engen, M. J., Lyngstad, S. H., Busch, C., Icick, R., Étain, B., et al. (2025) · International Journal of Bipolar Disorders · doi:10.1186/s40345-025-00388-5 · Cited by 2
Zeng, Y., Wu, H., Tan, X., Wang, R., Liu, Y., Wang, X., & Duan, J. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121685 · Cited by 3
Epidemiology of selected mental disorders in later life
Renn, B. N., Areán, P. A., & Unützer, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-800136-3.00002-8 · Cited by 2
Bokhan, N. A., Рощина, О. В., Simutkin, G. G., Levchuk, L. A., & Ivanova, S. А. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212203192 · Cited by 3
Bareis, N., Olfson, M., Dixon, L. B., Chwastiak, L., Monroe‐DeVita, M., Kessler, R. C., Gibbons, R. D., Edlund, M. J., Guyer, H., Kreski, N. T., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.133 · Cited by 2
Psychopathy and Mood Disorders
Dargis, M. A. (2022) · Dangerous behavior in clinical and forensic psychology · doi:10.1007/978-3-030-83156-1_8 · Cited by 2
Alshayea, A. K. (2024) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001816 · Cited by 1
Diaby, V., Pandey, S., Sanogo, V., Almutairi, R., Kanoria, Y., & Nag, S. S. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2025.31.1.60 · Cited by 1
Mogavero, M. C. (2025) · Springer eBooks · doi:10.1007/978-3-031-88816-8_3 · Cited by 1
Hsu, J.-W., Lin, W., Bai, Y., Huang, H.-H., Jeng, J., Tsai, S., & Chen, M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.08.023 · Cited by 2
Awasthi, S., Huang, D., Lynum, K. S. B., & Nag, S. S. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2026.32.1.66 · Cited by 1
Metadata
- Authors
- Blanco, C., Compton, W. M., Saha, T. D., Goldstein, B. I., Ruan, W. J., Huang, B., & Grant, B. F.
- Affiliations
- National Institute on Drug Abuse (US)
- National Institutes of Health (US)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Saha, Tulshi D.
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 84
- Pages
- 310-317
- ISSN
- 0022-3956 (ISSN-L)
- PMC
- PMC7416534
- OpenAlex
- W2529367653
- Cited by
- 149
- References
- 85
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 18 · 2023: 10 · 2022: 23 · 2021: 18 · 2020: 17 · 2019: 9 · 2018: 16 · 2017: 8
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Psychiatric Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- bipolar I disorder, prevalence, DSM-5, comorbidities, borderline personality disorder, schizotypal personality disorder, substance use disorders, anxiety disorders, quality of life, treatment rates, disability, socioeconomic factors, racial and ethnic disparities, sex differences, NESARC
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Bipolar Disorder, Disability Evaluation, Female, Humans, Interview, Psychological, Male, Middle Aged, Quality of Life, Sex Factors, Socioeconomic Factors, United States, Comorbidity, Prevalence, Diagnostic and Statistical Manual of Mental Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review